Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Colorcon
Merck
Boehringer Ingelheim
McKinsey

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

CIN-QUIN Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Cin-quin patents expire, and what generic alternatives are available?

Cin-quin is a drug marketed by Solvay and is included in five NDAs.

The generic ingredient in CIN-QUIN is quinidine sulfate. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the quinidine sulfate profile page.

Summary for CIN-QUIN
Drug patent expirations by year for CIN-QUIN
Synonyms for CIN-QUIN
(+)-Quinidine
(1S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol
(2-ethenyl- 4-azabicyclo [2.2.2] oct- 5-yl)- (6-methoxyquinolin- 4-yl)- methanol,
(3'.alpha., 9S)-6'-Methoxycinchonan-9-ol
(8R,9S)-6'-Methoxycinchonan-9-ol
(8R,9S)-Quinidine
(9S)-6 inverted exclamation mark -Methoxycinchonan-9-ol
(9S)-6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
(9S)-6'-Methoxycinchonan-9-ol
(R)-(6-methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol
(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol
(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(S)-(6-methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol
(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol
(S)-[(4S,5R,7R)-5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-(6-methoxyquinolin-4-yl)methanol
11010-73-4
1528764-92-2
500225-45-6
56-54-2
6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6470-EP1441224A2
6470-EP2272835A1
6470-EP2272844A1
6470-EP2272972A1
6470-EP2272973A1
6470-EP2275411A2
6470-EP2277872A1
6470-EP2305655A2
6470-EP2314576A1
6470-EP2314585A1
845886-64-8
882741-47-1
883881-01-4
898814-00-1
910899-51-3
AB00514657
AB01562940_01
AC1L9AHW
AC1Q4EZ6
ACT09863
AJ-45786
AK-57138
AKOS015920101
alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol (9S)-
Apo-Quinidine
AS-30538
Auriquin
AX8150056
BDBM50121975
beta-Quinidine
beta-Quinine
BIB1110
Biquin durules
bmse000511
BPBio1_000176
BR-57138
BRD-K59632282-052-01-5
BRD-K59632282-052-02-3
BRD-K70799801-311-02-7
BSPBio_000160
C20H24N2O2
Cardioquin
CCG-256507
CCRIS 672
CHEBI:28593
CHEMBL1294
Chinidin
Chinidin [German]
Chinidine
chinidinum
Cinchonan-9-ol, 6'-methoxy-, (9S)-
Conchinin
Conchinine
Conquinine
CPD000857275
CS-7812
DB00908
DTXSID4023549
Duraquin
EINECS 200-279-0
Epitope ID:141803
FT-0082277
GTPL2342
HMS2234L10
HMS3259O09
HSDB 225
HY-B1751
ITX08688JL
Kinidin
M-7594
MCULE-7178915526
MFCD00135581
MLS001335913
MLS001335914
MLS002548869
MolPort-003-804-058
MolPort-044-813-639
NC00478
NCGC00091231-01
NCGC00091231-02
NCGC00091231-03
NCI-C56246
Novoquinidin
Pitayin
Pitayine
Prestwick3_000280
PubChem7994
QDN
Quin-Release
Quinact
Quinaglute
Quinaglute Dura-Tabs
Quinalan
Quinatime
Quindine
Quinicardine
Quinicine
Quinidex
Quinidex Extentabs
quinidina
quinidine
Quinidine [BAN:NF]
QUINIDINE HYDROCHLORIDE
Quinidine sulfate
Quinidine, 98%, anhydrous
Quinidine, anhydrous
Quinidine, crystallized, >=98.0% (dried material, NT)
Quiniduran
Quinora
RW2069
SAM002264644
SC-05389
SC-88763
SCHEMBL15943
SCHEMBL17537608
SDCCGMLS-0066600.P001
SMR000857275
ST2413763
TCMDC-131239
UNII-ITX08688JL
W-109256
ZINC3831405
ZX-AFC000840

US Patents and Regulatory Information for CIN-QUIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay CIN-QUIN quinidine sulfate CAPSULE;ORAL 085296-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay CIN-QUIN quinidine sulfate TABLET;ORAL 084932-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay CIN-QUIN quinidine sulfate CAPSULE;ORAL 085297-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay CIN-QUIN quinidine sulfate TABLET;ORAL 085299-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay CIN-QUIN quinidine sulfate TABLET;ORAL 085298-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
McKinsey
AstraZeneca
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.